These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 9170118)

  • 21. Ginkgo biloba extract EGb 761 in dementia: intent-to-treat analyses of a 24-week, multi-center, double-blind, placebo-controlled, randomized trial.
    Kanowski S; Hoerr R
    Pharmacopsychiatry; 2003 Nov; 36(6):297-303. PubMed ID: 14663654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multifocal infarct dementia treated by cyclandelate and monitored by quantitative EEG.
    Harding GF; Hall P; Young J; Smith GA
    Angiology; 1978 Feb; 29(2):139-40. PubMed ID: 347986
    [No Abstract]   [Full Text] [Related]  

  • 23. Lack of effect of cyclandelate in peripheral arterial disease.
    Vyden JK; Nagasawa K; Kanazawa M; Rose HB; Seino Y; Groseth-Robertson MF; Lander EB; Elconin SB
    Angiology; 1984 Jan; 35(1):1-11. PubMed ID: 6364892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclandelate in the treatment of cerebral arteriosclerosis.
    Hall P
    J Am Geriatr Soc; 1976 Jan; 24(1):41-5. PubMed ID: 811704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic efficacy of vincamine in dementia.
    Fischhof PK; Möslinger-Gehmayr R; Herrmann WM; Friedmann A; Russmann DL
    Neuropsychobiology; 1996; 34(1):29-35. PubMed ID: 8884757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Evidence of a pharmacokinetic-pharmacodynamic relationship between pharmaco-EEG in healthy subjects after administration of cyclandelate].
    Dimpfel W; Schober F; Wedekind W; Kleinbloesem C; Coors C
    Arzneimittelforschung; 1994 Sep; 44(9):999-1004. PubMed ID: 7986255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclandelate in the management of tinnitus: a randomized, placebo-controlled study.
    Hester TO; Theilman G; Green W; Jones RO
    Otolaryngol Head Neck Surg; 1998 Mar; 118(3 Pt 1):329-32. PubMed ID: 9527112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonorganic insomnia in generalized anxiety disorder. 2. Comparative studies on sleep, awakening, daytime vigilance and anxiety under lorazepam plus diphenhydramine (Somnium) versus lorazepam alone, utilizing clinical, polysomnographic and EEG mapping methods.
    Saletu B; Saletu-Zyhlarz G; Anderer P; Brandstätter N; Frey R; Gruber G; Klösch G; Mandl M; Grünberger J; Linzmayer L
    Neuropsychobiology; 1997; 36(3):130-52. PubMed ID: 9313245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic efficacy of pyritinol in patients with senile dementia of the Alzheimer type (SDAT) and multi-infarct dementia (MID).
    Fischhof PK; Saletu B; Rüther E; Litschauer G; Möslinger-Gehmayr R; Herrmann WM
    Neuropsychobiology; 1992; 26(1-2):65-70. PubMed ID: 1475039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of early diabetic retinopathy with cyclandelate.
    Cunha-Vaz JG; Reis Fonseca J; Hagenouw JR
    Br J Ophthalmol; 1977 Jun; 61(6):399-404. PubMed ID: 326306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical experience with cyclandelate in insulin-dependent diabetic patients with neuropathy.
    De Leeuw IH; Van Rooy P; Moeremans M; Driessens M
    Drugs; 1987; 33 Suppl 2():125-30. PubMed ID: 3304951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for neuronal dysfunction in migraine: concurrence between specific qEEG findings and clinical drug response--a retrospective analysis-.
    Vonderheid-Guth B; Todorova A; Wedekind W; Dimpfel W
    Eur J Med Res; 2000 Nov; 5(11):473-83. PubMed ID: 11121368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R
    Pharmacopsychiatry; 1996 Mar; 29(2):47-56. PubMed ID: 8741021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of xantinolnicotinate in patients with dementia.
    Kanowski S; Fischhof PK; Grobe-Einsler R; Wagner G; Litschauer G
    Pharmacopsychiatry; 1990 May; 23(3):118-24. PubMed ID: 2197635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utility of the Mattis dementia rating scale to assess the efficacy of rivastigmine in dementia associated with Parkinson's disease.
    Dujardin K; Devos D; Duhem S; Destée A; Marié RM; Durif F; Lacomblez L; Touchon J; Pollak P; Péré JJ
    J Neurol; 2006 Sep; 253(9):1154-9. PubMed ID: 16998649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer's dementia in a randomized placebo-controlled double-blind study.
    Mazza M; Capuano A; Bria P; Mazza S
    Eur J Neurol; 2006 Sep; 13(9):981-5. PubMed ID: 16930364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EEG brain mapping and psychometry in age-associated memory impairment after acute and 2-week infusions with the hemoderivative Actovegin: double-blind, placebo-controlled trials.
    Saletu B; Grünberger J; Linzmayer L; Anderer P; Semlitsch HV
    Neuropsychobiology; 1990-1991; 24(3):135-48. PubMed ID: 2135068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Double-blind, placebo-controlled pharmacodynamic studies with a nutraceutical and a pharmaceutical dose of ademetionine (SAMe) in elderly subjects, utilizing EEG mapping and psychometry.
    Arnold O; Saletu B; Anderer P; Assandri A; di Padova C; Corrado M; Saletu-Zyhlarz GM
    Eur Neuropsychopharmacol; 2005 Oct; 15(5):533-43. PubMed ID: 16046102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Specific effects of cyclandelate on memory.
    Ananth J
    Drugs; 1987; 33 Suppl 2():97-102. PubMed ID: 3622311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topographic mapping of cognitive event-related potentials in a double-blind, placebo-controlled study with the hemoderivative Actovegin in age-associated memory impairment.
    Semlitsch HV; Anderer P; Saletu B; Hochmayer I
    Neuropsychobiology; 1990-1991; 24(1):49-56. PubMed ID: 2132641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.